David Abrams - Abrams Capital Management
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q1 | 0 | 0 | Sell 100.00% | 1.95 | |
| 2023 Q4 | 5,996,836 | 1.95 | Reduce 24.72% | 0.64 | $10.44 |
| 2023 Q3 | 7,966,433 | 2.68 | $10.20 | ||
| 2023 Q2 | 7,966,433 | 1.72 | $7.53 | ||
| 2023 Q1 | 7,966,433 | 2.23 | Reduce 50.00% | 2.23 | $8.85 |
| 2022 Q4 | 15,932,865 | 5.18 | Reduce 33.33% | 2.59 | $9.12 |
| 2022 Q3 | 23,899,296 | 5.56 | Reduce 0.61% | 0.03 | $8.07 |
| 2022 Q2 | 24,046,356 | 4.86 | $7.52 | ||
| 2022 Q1 | 24,046,356 | 5.27 | $9.39 | ||
| 2021 Q4 | 24,046,356 | 4.23 | $8.01 | ||
| 2021 Q3 | 24,046,356 | 5.11 | $9.74 | ||
| 2021 Q2 | 24,046,356 | 5.29 | $9.90 | ||
| 2021 Q1 | 24,046,356 | 6.25 | $11.54 | ||
| 2020 Q4 | 24,046,356 | 6.54 | $9.65 | ||
| 2020 Q3 | 24,046,356 | 6.85 | $9.01 | ||
| 2020 Q2 | 24,046,356 | 9.58 | $12.33 | ||
| 2020 Q1 | 24,046,356 | 8.50 | $8.98 | ||
| 2019 Q4 | 24,046,356 | 7.32 | $9.80 | ||
| 2019 Q3 | 24,046,356 | 4.63 | Add 33.25% | 1.16 | $6.88 |
| 2019 Q2 | 18,046,356 | 4.52 | $9.23 | ||
| 2019 Q1 | 18,046,356 | 7.95 | Reduce 2.57% | 0.21 | $15.68 |
| 2018 Q4 | 18,522,372 | 11.80 | Reduce 5.12% | 0.64 | $15.42 |
| 2018 Q3 | 19,522,372 | 11.12 | Reduce 1.12% | 0.13 | $21.54 |
| 2018 Q2 | 19,743,123 | 13.36 | $24.32 | ||
| 2018 Q1 | 19,743,123 | 10.58 | $17.09 | ||
| 2017 Q4 | 19,743,123 | 12.60 | Reduce 8.70% | 1.20 | $18.95 |
| 2017 Q3 | 21,623,886 | 14.85 | Buy | 14.85 | $17.60 |
| 2013 Q3 | 0 | 0 | Sell 100.00% | 5.82 | |
| 2013 Q2 | 2,561,269 | 5.82 | $39.20 | ||
| 2013 Q1 | 2,561,269 | 9.88 | $39.68 | ||
| 2012 Q4 | 2,561,269 | 8.76 | $37.34 |